INVA · All filings · Read this filing
What changed 10-Q
Item 1A. Risk Factors
2025-05-07 compared with 2024-11-06 · 0 added, 4 removed, 40 unchanged (9% of the section changed)
13 unchanged sentences
Specimen certificate representing the common stock of the registrant
−Removed: Indenture, dated as of January 4, 2013 by and between Theravance, Inc.
−Removed: and the Bank of New York Mellon Trust Company, N.A., as trustee
Form of 2.125% Convertible Subordinated Note Due 2023 (included in Exhibit 4.2)
16 unchanged sentences
Innoviva, Inc.
−Removed: November 6, 2024
/s/ Pavel Raifeld
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 6, 2024
/s/ Stephen Basso
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.